Related Experiment Video
Updated: Sep 21, 2025
09:08
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
1.9K
Drug Candidates for Autoimmune Diseases
Sabrina Saurin1,2, Myriam Meineck1,2, Gerhard Erkel3
11st Department of Medicine, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany.
Pharmaceuticals (Basel, Switzerland)
|May 28, 2022
Summary
Natural products from fungi, bacteria, and plants show potent anti-inflammatory effects, offering new avenues for immunosuppressive drugs. These compounds may reduce side effects and lower doses of existing treatments.
Area of Science:
- Microbiology and Pharmacology
- Natural Product Chemistry
- Immunology
Background:
- Many immunosuppressants originate from microbial or plant sources.
- Existing immunosuppressive drugs have limitations due to side effects.
- Need for novel immunosuppressants to manage autoimmune diseases and organ transplant rejection.
Purpose of the Study:
- To review natural products with anti-inflammatory properties for autoimmune diseases.
- To assess the potential of these natural products as new immunosuppressive agents.
- To highlight candidates that have progressed to clinical trials.
Main Methods:
- Comprehensive literature review of natural products with anti-inflammatory activity.
- Analysis of studies testing these compounds in models of chronic inflammatory autoimmune diseases.
- Evaluation of mechanisms of action, including NF-κB signaling and oxidative stress inhibition.
Main Results:
- Natural products demonstrate anti-inflammatory potency comparable to established drugs.
- Some candidates have successfully completed initial clinical trials.
- Common mechanisms involve inhibiting inflammatory pathways (e.g., NF-κB) and reducing oxidative stress.
Conclusions:
- Natural products are promising sources for developing new immunosuppressive drugs.
- Potential to supplement standard therapies, reducing side effects and drug dosages.
- Further research, including chemical modification for bioavailability and safety studies, is warranted.
Related Concept Videos
01:29Autoimmune Disorders
688
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
688
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
243
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
243
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
212
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
212
01:29Inflammatory Bowel Disease IV: Pharmacological Management
206
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
206
01:27Tumor Immunotherapy
677
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677